82P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacira Biosciences Inc

Watchlist Manager

Watchlist

Price: 23.6 EUR 1.72% Market Closed

Market Cap: €2B

P	Pacira Biosciences Inc SWB:82P	US
	Promotora y Operadora de Infraestructura SAB de CV OTC:PYOIF	MX
	Hon Hai Precision Industry Co Ltd TWSE:2317	TW
	Polygiene Group AB F:44P	SE
G	Guangdong Investment Ltd F:GUG	HK
	Merck KGaA F:MRKC	DE
M	Muenchener Rueckversicherungs Gesellschaft in Muenchen AG XBER:MUV2	DE
B	Bayerische Motoren Werke AG XMUN:BMW	DE
G	Givaudan SA XBER:GIN	CH
E	East Japan Railway Co XBER:EJR	JP
A	Accenture PLC SWB:CSA	IE
B	BCE Inc NYSE:BCE	CA
	Five Star Bancorp NASDAQ:FSBC	US
C	Compal Electronics Inc LSE:CEIR	TW
	TD Synnex Corp NYSE:SNX	US

Profitability Summary

Pacira Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

76%

Gross Margin is Increasing

69% > 79%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

10% > 5%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-1% > 2%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

19% > 24%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.